- Home
- RHE vs PHIO Comparison
RHE vs PHIO Comparison
Compare RHE & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RHE
- PHIO
- Stock Information
- Founded
- RHE 1988
- PHIO 2011
- Country
- RHE United States
- PHIO United States
- Employees
- RHE N/A
- PHIO N/A
- Industry
- RHE Real Estate
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- RHE Real Estate
- PHIO Health Care
- Exchange
- RHE Nasdaq
- PHIO Nasdaq
- Market Cap
- RHE 2.9M
- PHIO 3.4M
- IPO Year
- RHE 2006
- PHIO N/A
- Fundamental
- Price
- RHE $2.29
- PHIO $2.77
- Analyst Decision
- RHE
- PHIO Strong Buy
- Analyst Count
- RHE 0
- PHIO 1
- Target Price
- RHE N/A
- PHIO $36.00
- AVG Volume (30 Days)
- RHE 2.2M
- PHIO 18.5M
- Earning Date
- RHE 11-19-2024
- PHIO 11-14-2024
- Dividend Yield
- RHE N/A
- PHIO N/A
- EPS Growth
- RHE N/A
- PHIO N/A
- EPS
- RHE N/A
- PHIO N/A
- Revenue
- RHE $15,753,000.00
- PHIO N/A
- Revenue This Year
- RHE N/A
- PHIO N/A
- Revenue Next Year
- RHE N/A
- PHIO N/A
- P/E Ratio
- RHE N/A
- PHIO N/A
- Revenue Growth
- RHE N/A
- PHIO N/A
- 52 Week Low
- RHE $1.13
- PHIO $1.53
- 52 Week High
- RHE $6.80
- PHIO $10.35
- Technical
- Relative Strength Index (RSI)
- RHE 57.17
- PHIO 50.99
- Support Level
- RHE $1.78
- PHIO $2.41
- Resistance Level
- RHE $2.58
- PHIO $4.53
- Average True Range (ATR)
- RHE 0.53
- PHIO 0.83
- MACD
- RHE 0.02
- PHIO 0.12
- Stochastic Oscillator
- RHE 16.33
- PHIO 14.18
About RHE Regional Health Properties Inc.
Regional Health Properties Inc is a self-managed healthcare real estate investment company that invests in real estate purposed for senior living and long-term healthcare through facility lease and sub-lease transactions. It has two reportable segments real estate segment and the healthcare services segment. It derives the majority of its revenue from the healthcare services segment. Its portfolio of properties is diversified across various states, with concentrations in Georgia and Ohio.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.